1. Home
  2. ERIC vs ILMN Comparison

ERIC vs ILMN Comparison

Compare ERIC & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ericsson

ERIC

Ericsson

HOLD

Current Price

$9.67

Market Cap

32.1B

Sector

Technology

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$135.32

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERIC
ILMN
Founded
1876
1998
Country
Sweden
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.1B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ERIC
ILMN
Price
$9.67
$135.32
Analyst Decision
Hold
Hold
Analyst Count
1
16
Target Price
$9.80
$117.31
AVG Volume (30 Days)
7.0M
1.7M
Earning Date
01-23-2026
02-05-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
N/A
EPS
0.78
4.46
Revenue
$25,502,929,121.00
$4,288,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.24
P/E Ratio
$12.45
$30.53
Revenue Growth
N/A
N/A
52 Week Low
$6.64
$68.70
52 Week High
$10.35
$153.06

Technical Indicators

Market Signals
Indicator
ERIC
ILMN
Relative Strength Index (RSI) 54.16 62.29
Support Level $9.54 $129.29
Resistance Level $9.76 $138.80
Average True Range (ATR) 0.10 3.96
MACD 0.00 -0.36
Stochastic Oscillator 58.06 71.84

Price Performance

Historical Comparison
ERIC
ILMN

About ERIC Ericsson

Ericsson provides telecom equipment and services that are primarily used to build and operate mobile networks. The firm divides its business into three segments: networks, cloud and software services, and enterprise. Wireless carriers have traditionally been the firm's primary customers, but it is pushing to cater more to enterprises as well, as both try to take advantage of 5G capabilities and utilize "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: